CRIS IL📊 Leads🔑 Keywords📋 Keyword Review📄 Papers🎤 Conference📬 Reports⚙ Config
S

Suvendu Giri

Faculty of Biology  ·  Weizmann Institute
H-index: 7  ·  Citations: 225  ·  Papers: —
✉ not listed
View on CRIS ↗ ORCID ↗

Matched Keywords

decision making
Deprioritized:cancercelldnaprotein

Research Areas (CRIS Fingerprint)

Nitric OxideThalidomideOsimertinibResistant CellsSecondary mutationTeratogenTherapeutic PotentialCetuximabMutatorEGFR InhibitorsAntibioticsTumorDormancyAutophagyRe-epithelializationDNA DamageCancer CellsBreast Cancer RelapseVascular DiseaseRepurposingGenetic ResistanceCancer PatientsLung DiseaseMolecular ActionTarget PathwaysUvaria NarumEarly DiagnosisAntibacterial PropertiesAntiangiogenic PropertiesLeaf ExtractGreen Silver NanoparticlesMedicinal PlantsNitric Oxide Synthase InhibitorsCOVID-19Response PredictorsEpidermal Growth Factor Receptor-tyrosine Kinase Inhibitor (EGFR-TKI)Lung Cancer ModelPotential BiomarkersAnti-EGFR AntibodyDacomitinibVon Willebrand FactorLung DevelopmentPlasma NitriteChemotherapyBreast Cancer DrugsOxidative StressProtein S-nitrosylationDNA ReplicationError-proneHypermutatorEpidermal Growth Factor ReceptorLung CancerTyrosine-Kinase InhibitorAntiinfective AgentOsimertinibDrug ResistanceReceptorMalignant NeoplasmEthinylestradiol Plus Norethisterone AcetateDrug TherapyCardiovascular SystemCetuximabCell LineCardiotoxicityInteraction NetworkDisease ProcessSignaling MoleculeSilver NanoparticleGreen SynthesisNitriteBiological FunctionsEarly DiagnosisNitric Oxide SynthaseVon Willebrand FactorVasodilatationVascular DiseaseBispecific AntibodyAntiangiogenicBiological MarkerSynaptic TransmissionDNA SynthesisCancer ModelChemotherapyXenograftNeoplasmMutagenic AgentEGFR InhibitorsPhosphotransferase InhibitorAntibioticsSOS ResponseAnticarcinogenSignal TransductionCardiologyTarget ProteinCyprinusCardiovascular DiseaseDecision MakingVasculotropinPharmacophoreIn SilicoEpidermal Growth Factor ReceptorProtein Tyrosine Kinase InhibitorAntiinfective AgentOsimertinibLung CancerMalignant NeoplasmDiseaseReceptorCetuximabCardiotoxicityVascular DiseaseInfectionBispecific AntibodyVon Willebrand FactorRepurposingAntiangiogenicMedicinal PlantTherapeutic UseBiological MarkerSilver NanoparticleSilver NanoparticleUvariaChemotherapyNitriteDacomitinibCancer ModelNitric Oxide SynthaseNeoplasmDrug ResistanceAnticarcinogenFluorouracilVasculotropinCardiovascular DiseaseCoronavirinaePhosphotransferase InhibitorThalidomideFetus DiseaseTranscriptomeLenalidomideReactive Oxygen MetaboliteCytotoxicityScanning Electron MicroscopyCyclineCarpMonotherapyMonoclonal AntibodyChickLactate DehydrogenaseChemical AgentCadmium Oxide

Publications (9 linked — showing top 20)

TMPRSS2-ERG confers resistance of prostate cancer to antiandrogens2026
Re-epithelialization of cancer cells increases autophagy and DNA damage: Implications for breast cancer dormancy and relapse2025
A bispecific antibody targeting EGFR and AXL delays resistance to osimertinib2024
L858R emerges as a potential biomarker predicting response of lung cancer models to anti-EGFR antibodies: Comparison of osimertinib vs. cetuximab2023
Green Synthesis of Silver Nanoparticles Using the Leaf Extract of the Medicinal Plant, Uvaria narum and Its Antibacterial, Antiangiogenic, Anticancer and Catalytic Properties2023
Therapeutic Prospects of Nitric Oxide as an Anti-teratogen2023
AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer2022
Repurposing of thalidomide and its derivatives for the treatment of SARS-coV-2 infections: Hints on molecular action2021
Host-dependent phenotypic resistance to EGFR tyrosine kinase inhibitors2021